The Gut and Intestinal Bacteria in Chronic Heart Failure

E-ISSN： 1875-5453|10|1|22-28

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.10, Iss.1, 2009-01, pp. : 22-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Valsartan: In Chronic Heart Failure

By Wellington K. Goa K.L.

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 4, 2002-01 ,pp. : 267-274

Adis International

Access to resources Recommend Favorite

Pharmacologic Therapy of Chronic Heart Failure

By Hamad Eman Mather Paul J. Srinivasan Siva Rubin Sharon Whellan David J. Feldman Arthur M.

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 4, 2007-01 ,pp. : 235-248

Adis International

Access to resources Recommend Favorite

Carvedilol in the treatment of chronic heart failure

By Moe G.

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 5, 2001-05 ,pp. : 831-843

Informa Healthcare

Access to resources Recommend Favorite

Neuroimmune Activation in Chronic Heart Failure

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 13, Iss. 1, 2013-03 ,pp. : 68-75

Bentham Science Publishers

Access to resources Recommend Favorite

Animal Models of Chronic Heart Failure

By Muders F. Elsner D.

Pharmacological Research, Vol. 41, Iss. 6, 2000-06 ,pp. : 605-612

Academic Press

Access to resources Recommend Favorite